Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sum Lam

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Heart Disease (Hagerstown, Md.)|June 5, 2003
Insulin glargine: a new once-daily basal insulin for the management of type 1 and type 2 diabetes mellitusSum Lam
Cardiology in Review|October 11, 2011
Azilsartan: a newly approved angiotensin II receptor blockerSum Lam
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|August 23, 2012
Linezolid-associated thrombocytopeniaSum Lam
Cardiology in Review|March 29, 2013
Apixaban: a new factor Xa inhibitor for stroke prevention in patients with nonvalvular atrial fibrillationSum Lam
Cardiology in Review|June 22, 2006
Exenatide: a novel incretin mimetic agent for treating type 2 diabetes mellitusSum Lam, Sharon See
Cardiology in Review|August 19, 2007
Sitagliptin: a novel drug for the treatment of type 2 diabetesMary Choy, Sum Lam
Clinical Interventions in Aging|November 30, 2007
Pharmacologic management of overactive bladderSum Lam, Olga Hilas
Cardiology in Review|January 13, 2015
Omega-3-carboxylic acid (Epanova) for hypertriglyceridemiaAlan Zhao, Sum Lam
Cardiology in Review|April 30, 2015
Vorapaxar: A Protease-Activated Receptor Antagonist for the Prevention of Thrombotic EventsSum Lam, Tran Tran
Cardiology in Review|June 12, 2010
Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for type 2 diabetesSum Lam, Maha Saad
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Heart Disease (Hagerstown, Md.)|June 5, 2003
Insulin glargine: a new once-daily basal insulin for the management of type 1 and type 2 diabetes mellitusSum Lam
Cardiology in Review|October 11, 2011
Azilsartan: a newly approved angiotensin II receptor blockerSum Lam
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|August 23, 2012
Linezolid-associated thrombocytopeniaSum Lam
Cardiology in Review|March 29, 2013
Apixaban: a new factor Xa inhibitor for stroke prevention in patients with nonvalvular atrial fibrillationSum Lam
Cardiology in Review|June 22, 2006
Exenatide: a novel incretin mimetic agent for treating type 2 diabetes mellitusSum Lam, Sharon See
Cardiology in Review|August 19, 2007
Sitagliptin: a novel drug for the treatment of type 2 diabetesMary Choy, Sum Lam
Clinical Interventions in Aging|November 30, 2007
Pharmacologic management of overactive bladderSum Lam, Olga Hilas
Cardiology in Review|January 13, 2015
Omega-3-carboxylic acid (Epanova) for hypertriglyceridemiaAlan Zhao, Sum Lam
Cardiology in Review|April 30, 2015
Vorapaxar: A Protease-Activated Receptor Antagonist for the Prevention of Thrombotic EventsSum Lam, Tran Tran
Cardiology in Review|June 12, 2010
Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for type 2 diabetesSum Lam, Maha Saad
Pageof 9